Knight Therapeutics, Inc. (GUD.TO)
12.06
+0.01
(+0.08%)
CAD |
TSX |
Nov 13, 16:00
Knight Therapeutics Price : 12.06 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 12.10 | 12.18 | 11.89 | 12.06 | 45575.00 |
| Nov 12, 2026 | 12.04 | 12.06 | 11.88 | 12.05 | 40845.00 |
| Nov 11, 2026 | 11.89 | 12.12 | 11.89 | 12.03 | 61025.00 |
| Nov 10, 2026 | 11.60 | 12.17 | 11.55 | 11.98 | 156918.0 |
| Nov 09, 2026 | 11.40 | 11.89 | 11.37 | 11.60 | 146264.0 |
| Nov 06, 2026 | 11.81 | 11.86 | 11.27 | 11.42 | 74637.00 |
| Nov 05, 2026 | 11.84 | 11.86 | 11.29 | 11.56 | 162847.0 |
| Nov 04, 2026 | 11.31 | 11.32 | 10.90 | 11.30 | 66643.00 |
| Nov 03, 2026 | 11.32 | 11.33 | 11.18 | 11.26 | 28638.00 |
| Nov 02, 2026 | 11.34 | 11.44 | 11.26 | 11.32 | 71775.00 |
| Oct 30, 2026 | 11.34 | 11.41 | 11.25 | 11.27 | 15766.00 |
| Oct 29, 2026 | 11.34 | 11.43 | 11.28 | 11.40 | 62809.00 |
| Oct 28, 2026 | 11.28 | 11.41 | 11.23 | 11.31 | 43954.00 |
| Oct 27, 2026 | 11.63 | 11.66 | 11.21 | 11.28 | 73324.00 |
| Oct 26, 2026 | 11.60 | 11.64 | 11.45 | 11.63 | 68922.00 |
| Oct 23, 2026 | 11.70 | 11.71 | 11.51 | 11.61 | 29683.00 |
| Oct 22, 2026 | 11.70 | 11.83 | 11.55 | 11.70 | 61590.00 |
| Oct 21, 2026 | 11.45 | 11.71 | 11.34 | 11.70 | 70523.00 |
| Oct 20, 2026 | 11.34 | 11.54 | 11.26 | 11.45 | 48483.00 |
| Oct 19, 2026 | 11.10 | 11.35 | 11.10 | 11.31 | 93763.00 |
| Oct 16, 2026 | 10.85 | 11.16 | 10.83 | 11.04 | 82225.00 |
| Oct 15, 2026 | 10.79 | 10.80 | 10.58 | 10.80 | 47766.00 |
| Oct 14, 2026 | 10.65 | 10.73 | 10.59 | 10.61 | 67012.00 |
| Oct 13, 2026 | 10.84 | 10.84 | 10.65 | 10.68 | 93745.00 |
| Oct 09, 2026 | 10.66 | 11.00 | 10.40 | 10.83 | 76841.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| HLS Therapeutics, Inc. | 3.71 |
| Bausch Health Cos., Inc. | 11.91 |
| Cipher Pharmaceuticals, Inc. | 14.17 |
| BioSyent, Inc. | 17.79 |
| Revive Therapeutics Ltd. | 0.015 |
Price Related Metrics
| PE Ratio | 74.95 |
| PS Ratio | 2.111 |
| Price to Book Value | 1.490 |
| Price to Free Cash Flow | 10.31 |
| Earnings Yield | 1.33% |
| Market Cap | 1.185B |
| Operating PE Ratio | 38.02 |
| Normalized PE Ratio | 47.86 |